Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing